Brain Pathology · 2003 · 137 citations · 38 references
MedicineMolecular BiologyOncologyDna RepairMolecular OncologyNeoplasiaBrain TumorsCancer EpigeneticsDna MethylationDna Repair In CarcinogenesisEpigenetic Alterations In CancerMalignant NeoplasmsAberrant Dna MethylationDna MethyltransferasesO6-methylguanine-dna Methyltransferase RepairP53 AbnormalityP53 MutationPromoter HypermethylationPromoter MethylationRepair Of Methylating Agent Damage
The O6-methylguanine-DNA methyltransferase (MGMT) plays a major role in repairing DNA damage from alkylating agents. In several human neoplasms including low-grade diffuse astrocytomas, promoter hypermethylation of MGMT has been shown to correlate with an increased frequency of p53 mutation. In the present study, we analyzed MGMT promoter methylation by the methylation-specific PCR in 49 newly diagnosed WHO grade II astrocytomas and evaluated its clinical usefulness. MGMT promoter methylation was found in 21 (43%) of the 49 tumors. A tight correlation existed between MGMT methylation and p53 protein accumulation (P=0.0424). The presence of MGMT methylation was significantly associated with a shorter progression free survival (PFS) on both univariate analysis (P=0.0014) and multivariate analysis (P=0.0081). It was a more powerful determinant of the PFS than age, sex, performance status, proliferative activity, or p53 expression, and was independent of the extent of surgery. In terms of the overall survival, MGMT methylation demonstrated a prognostic utility in the univariate analysis but not in the multivariate analysis. The present findings indicate that aberrant methylation of the MGMT promoter independently augurs for an unfavorable clinical course in patients with low-grade diffuse astrocytomas. Since the presence of MGMT methylation is expected to predict an increased sensitivity to alkylating chemotherapeutic agents, earlier chemotherapy could serve to improve an unfavorable natural history in tumors with MGMT methylation.
38
Pathology and Genetics of Tumours of the Nervous System
Michael Brada · British Journal of Cancer · 2001 · 793 citations · Full text
Genetic studies of the lac repressor
Christine Coulondre, Jeffrey H Miller · Journal of Molecular Biology · 1977 · 605 citations